System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Guillaume Baudry, MD, PhD is an expert in Cardiology at Centre Hospitalier Universitaire de Nancy (France). As of October 2026, ScienceLeadR ranks Guillaume Baudry in the top 1% of experts worldwide for Heart Failure. Guillaume Baudry has authored 121 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 3 of them ongoing. SLR score: 636 (community average: 125). How the SLR is computed.

LeadR Profile

Guillaume Baudry, MD, PhD Centre Hospitalier Universitaire de Nancy France
636 ScienceLeadR Reputation 636

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Transplantation - Critical Care

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2018 - 2026
Source: PubMed

Centre Hospitalier Universitaire de Nancy

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 121

Citations

Citations: 498 1st author: 42 Last author: 7 Unique author: 2

Main journals

Eur J Heart Fail 30
ESC Heart Fail 15
Arch Cardiovasc Dis 7
Archives of Cardiovascular Diseases Supplements 6
J Heart Lung Transplant 5

Best Journals

Eur Heart J 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Trends in mortality, heart transplantation, and left ventricular assist device use in advanced heart failure between 2003 and 2022: data from the Swedish Heart Failure Registry.
PMID 42485618 — registries, mortality, heart failure, heart, heart failure, systolic, heart transplantation, therapeutics, transplantation, prognosis		Eur J Heart Fail20261
Redefining Cardiometabolic Disease: Expert Consensus on the CardioVascular-Kidney-Liver-Metabolic (CVKLM) Multiorgan Staging.
PMID 42945405 — liver diseases, diabetes mellitus, heart, cardiovascular diseases, kidney, liver, obesity, therapeutics		Eur J Prev Cardiol20260
The complexity of congestion in heart failure: a critical review of the evidence and a proposal for a multimodality approach.
PMID 42895733 — hospitalization, heart failure, heart, cardiovascular diseases, tissues		Eur Heart J Qual Care Clin Outcomes20260
Sexual Health in Heart Failure: How Age, Sex, and Dyspnea Interact to Shape Intimacy and Unmet Clinical Needs.
PMID 42895114 — heart failure, heart, sexuality, sex, therapeutics, dyspnea		ESC Heart Fail20260
Management of Heart transplant recipients for the non Heart Transplant health care provider. A Clinical Consensus Statement of the Heart Failure Association (HFA) and the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC.
PMID 42895118 — heart failure, heart, nursing, cardiovascular nursing, health personnel, occupations, transplants, therapeutics, immunosuppression therapy, transplantation		Eur J Heart Fail20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 6
Phase 2 1

By status:

Completed 3
Recruiting 3
Withdrawn 1

By type:

Interventional 7

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 1
multicentricup10 2

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Evaluation of the Effects of Sauna Therapy on Congestion and Loop Diuretic Use in Patients With Heart Failure With Reduced or Moderately Reduced Ejection Fraction
NCT07468344 — hospitalization, heart failure, baths, heart, cardiac rehabilitation, steam, rehabilitation, steam bath, recycling, diuretics, posture, therapeutics		N/ARecruiting2026
Acute Reno Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List
NCT06868797 — kidney diseases, research design, blood, waiting lists, plasminogen, heart failure, plasminogen activators, heart, kidney, transplants, research, therapeutics		N/ARecruiting2025
LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients
NCT04768322 — enzyme inhibitors, sodium-glucose transporter 2 inhibitors, angiotensin ii, receptors, angiotensin, angiotensin-converting enzyme inhibitors, heart failure, heart, symporters, peptidyl-dipeptidase a, signs and symptoms, neprilysin, receptors, mineralocorticoid, angiotensins, enzymes, heart failure, systolic, maximum tolerated dose, therapeutics, mineralocorticoids, random allocation, mineralocorticoid receptor antagonists		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS